Chime investor to sell 95K shares under Rule 144

Crosslink funds file a Rule 144 notice to sell 95,400 shares of Chime Financial (CHYM) common stock and disclose recent sizable share sales.

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) is the issuer for which CROSSLINK CROSSOVER FUND VI is filing a notice under Rule 144 to sell restricted common shares. The fund plans to sell 95,400 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $3,025,486.98 and trading on NASDAQ.

The securities to be sold were originally acquired on October 27, 2014 in a private acquisition from the issuer or an affiliate for cash. The notice also lists multiple sales of Chime common stock by related Crosslink entities during the past three months, including large transactions on September 10–15, 2026.

Key Figures

Shares planned for sale: 95,400 shares Aggregate market value of planned sale: $3,025,486.98 Acquisition date of securities: October 27, 2014 +3 more

6 metrics

Shares planned for sale 95,400 shares Common stock to be sold under Rule 144 by CROSSLINK CROSSOVER FUND VI

Aggregate market value of planned sale $3,025,486.98 Value of 95,400 shares of Chime common stock listed in the securities information section

Acquisition date of securities October 27, 2014 Date the securities to be sold were acquired in a private acquisition from issuer/affiliate

Past sale by Crosslink Crossover Fund VI on September 15, 2026 95,400 shares for $3,167,280.00 Recorded in the “Securities Sold During The Past 3 Months” section

Past sale by Crosslink Crossover Fund VII on September 15, 2026 54,600 shares for $1,812,720.00 Recorded in the “Securities Sold During The Past 3 Months” section

Past sale by Crosslink Ventures VII Holdings on September 11, 2026 161,090 shares for $5,298,201.77 Recorded in the “Securities Sold During The Past 3 Months” section

Key Terms

Rule 144, Private Acquisition from Issuer/Affiliate, aggregate market value, restricted securities

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Private Acquisition from Issuer/Affiliate financial

"Common | 10/27/2014 | Private Acquisition from Issuer/Affiliate | Issuer"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 95400 | 3025486.98"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

restricted securities regulatory

"Notice to be filed for the sale of restricted securities under Rule 144."

Restricted securities are shares or other investment instruments that come with legal or contractual limits on when and how they can be sold, like stock given to founders or bought in a private offering. Think of them as assets in a locked box that can’t be freely traded until certain conditions — such as a waiting period, company registration, or specific approvals — are met. For investors this matters because restricted securities are less liquid and can affect timing, price, and perceived value when they eventually enter the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for CHYM shareholders?

The filing reports that Crosslink-affiliated funds intend to sell 95,400 shares of Chime Financial common stock under Rule 144. It is a required notice for resales of restricted or control securities and discloses planned and recent sales, but it does not change Chime’s capital structure by itself.

How many CHYM shares are planned to be sold under this Form 144?

CROSSLINK CROSSOVER FUND VI plans to sell 95,400 shares of Chime Financial common stock. The filing lists this amount in the securities information section, along with an aggregate market value and broker details.

What is the aggregate market value of the CHYM shares covered by this notice?

The Form 144 states an aggregate market value of $3,025,486.98 for the 95,400 shares of Chime Financial common stock that CROSSLINK CROSSOVER FUND VI plans to sell through Morgan Stanley Smith Barney LLC.

When and how did the seller originally acquire the CHYM shares?

The securities to be sold were acquired on October 27, 2014 in a Private Acquisition from Issuer/Affiliate for cash. This is disclosed in the “Securities To Be Sold” section of the Form 144 notice.

What recent CHYM share sales by Crosslink entities are disclosed?

Disclosed past three‑month sales include CROSSLINK CROSSOVER FUND VI selling 95,400 shares for $3,167,280.00 and CROSSLINK CROSSOVER FUND VII selling 54,600 shares for $1,812,720.00 on September 15, 2026, plus several other sizable transactions on September 10–14, 2026.

Which broker will handle the planned CHYM share sale under this Form 144?

The planned sale of 95,400 shares of Chime Financial common stock will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as stated in the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:27 PM Accepted by SEC EDGAR 09/16/2026 - 04:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001514687
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CHIME FINANCIAL, INC.
SEC File Number	001-42693
Address of Issuer	101 CALIFORNIA STREET, SUITE 500 SAN FRANCISCO CALIFORNIA 94111
Phone	844-244-6363
Name of Person for Whose Account the Securities are To Be Sold	CROSSLINK CROSSOVER FUND VI, LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	95400	3025486.98	347019852	09/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2014	Private Acquisition from Issuer/Affiliate	Issuer			95400	10/27/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CROSSLINK CROSSOVER FUND VI, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/15/2026	95400	3167280.00
CROSSLINK CROSSOVER FUND VII, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/15/2026	54600	1812720.00
CROSSLINK CROSSOVER FUND VI, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/14/2026	95400	3252329.10
CROSSLINK CROSSOVER FUND VII, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/14/2026	54600	1861395.90
CROSSLINK CROSSOVER FUND VI, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/11/2026	97308	3213947.01
CROSSLINK CROSSOVER FUND VII, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/11/2026	55692	1839428.79
CROSSLINK VENTURES VII HLDGS, LLC 101 California Street Suite 500 San Francisco CA 94111	Common	09/11/2026	161090	5298201.77
CROSSLINK CROSSOVER FUND VI, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/10/2026	93492	3099035.42
CROSSLINK CROSSOVER FUND VII, LP 101 California Street Suite 500 San Francisco CA 94111	Common	09/10/2026	53508	1773661.78

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Maureen Offer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)